Vedolizumab and Infliximab Combination Therapy in the Treatment of Crohn's Disease

被引：34
|
作者：
Hirten, Robert [1 ]
Longman, Randy S. [2 ]
Bosworth, Brian P. [2 ]
Steinlauf, Adam [2 ]
Scherl, Ellen [2 ]
机构：
[1] North Shore Long Isl Jewish Hlth Syst, Hofstra North Shore LIJ Sch Med, Div Gastroenterol, New Hyde Pk, NY USA
[2] Jill Roberts Ctr Inflammatory Bowel Dis, New York, NY 10021 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2015年 / 110卷 / 12期
关键词：
RANDOMIZED-TRIAL; INDUCTION;
D O I：
10.1038/ajg.2015.355
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1737 / 1738
页数：3
相关论文
共 50 条
  • [1] Azathioprine and Infliximab: Monotherapy or Combination Therapy in the Treatment of Crohn's Disease
    Love, Bryan L.
    Smith, Lisa S.
    Sarbah, Steedman A.
    Fowler, Fred C.
    [J]. CLINICAL MEDICINE INSIGHTS-GASTROENTEROLOGY, 2011, 4 : 21 - 30
  • [2] Infliximab, azathioprine or combination therapy in the treatment of active Crohn's disease
    Cottone, Mario
    Papi, Claudio
    Orlando, Ambrogio
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (06) : 709 - 712
  • [3] Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
    Herrlinger, Klaus R.
    Stange, Eduard F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (11): : 1086 - 1086
  • [4] Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease REPLY
    Colombel, Jean Frederic
    Sandborn, William J.
    Rutgeerts, Paul
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (11): : 1087 - 1088
  • [5] Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
    Colombel, Jean Frederic
    Sandborn, William J.
    Reinisch, Walter
    Mantzaris, Gerassimos J.
    Kornbluth, Asher
    Rachmilewitz, Daniel
    Lichtiger, Simon
    D'Haens, Geert
    Diamond, Robert H.
    Broussard, Delma L.
    Tang, Kezhen L.
    van der Woude, C. Janneke
    Rutgeerts, Paul
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (15): : 1383 - 1395
  • [6] Discontinuation of infliximab in patients with Crohn's disease on combination therapy
    Hindson, Jordan
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (03) : 131 - 131
  • [7] Discontinuation of infliximab in patients with Crohn’s disease on combination therapy
    Jordan Hindson
    [J]. Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 131 - 131
  • [8] Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER)
    Colombel, Jean-Frederic
    Ungaro, Ryan C.
    Sands, Bruce E.
    Siegel, Corey A.
    Wolf, Douglas C.
    Valentine, John F. .
    Feaga, Brian G.
    Neustifter, Blue
    Kadali, Harisha
    Nazarey, Pradeep
    James, Alexandra
    Jairath, Vipul
    Khan, Rana M. Qasim
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (07)
  • [9] Vedolizumab in the treatment of Crohn's disease
    Gisbert, Javier P.
    Domenech, Eugeni
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2015, 38 (05): : 338 - 348
  • [10] Vedolizumab for the treatment of Crohn's disease
    Argollo, Marjorie
    Fiorino, Gionata
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (03) : 179 - 189
12345